FAM
RAPT

Fred Alger Management’s RAPT Therapeutics RAPT Stock Holding History

Fred Alger Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,475
Closed -$5.66M – 488
2023
Q4 		$5.66M Buy
28,475
+17,753
+166% +$2.2M 0.03% 235
2023
Q3 		$1.43M Sell
10,722
-9,083
-46% -$1.48M 0.01% 346
2023
Q2 		$2.96M Sell
19,805
-4,756
-19% -$741K 0.02% 296
2023
Q1 		$3.61M Buy
24,561
+23,790
+3,086% +$4.81M 0.02% 286
2022
Q4 		$122K Buy
+771
New +$123K ﹤0.01% 443

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fred Alger Management's RAPT Position: Q1 2024 in Review

Fred Alger Management sold out of RAPT Therapeutics (RAPT) in Q1 2024, closing a stake of 28,475 shares — an estimated $5.66M sold.

Fred Alger Management first reported a position in RAPT in Q4 2022 and held it in 5 quarters. The position peaked at $5.66M in Q4 2023. 121 funds tracked by Wall St. Rank hold RAPT as of Q1 2024.

  • Fred Alger Management reported no remaining RAPT Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Fred Alger Management sold 28,475 RAPT Therapeutics shares in Q1 2024, an estimated $5.66M.
  • Fred Alger Management first reported a position in RAPT Therapeutics in Q4 2022 and held it in 5 quarters.
  • Fred Alger Management's RAPT Therapeutics position peaked at $5.66M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.